Bridges Lance Form 4 ENTROPIC COMMUNICATIONS / Lance Bridges ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bridges Lance

(Last) (First) (Middle)

6290 SEQUENCE DRIVE

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ENTROPIC COMMUNICATIONS INC [ ENTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Senior VP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2015

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2015		D		126,073	D	(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.99	04/30/2015		D			40,665	(2)	03/19/2018	Common Stock	40,665	(2)	0	D
Non-Qualified Stock Option (right to buy)	$2.41	04/30/2015		D			62,502	(3)	05/21/2019	Common Stock	62,502	(3)	0	D
Non-Qualified Stock Option (right to buy)	$3.86	04/30/2015		D			60,000	(4)	04/11/2024	Common Stock	60,000	(4)	0	D
Non-Qualified Stock Option (right to buy)	$4.11	04/30/2015		D			60,000	(5)	04/12/2023	Common Stock	60,000	(5)	0	D
Non-Qualified Stock Option (right to buy)	$4.86	04/30/2015		D			80,000	(6)	04/08/2020	Common Stock	80,000	(6)	0	D
Non-Qualified Stock Option (right to buy)	$5.1	04/30/2015		D			51,000	(7)	04/13/2022	Common Stock	51,000	(7)	0	D
Non-Qualified Stock Option (right to buy)	$7.45	04/30/2015		D			66,500	(8)	04/13/2021	Common Stock	66,500	(8)	0	D
Restricted Stock Unit	(9)	04/30/2015		D			41,800	(9)	(9)	Common Stock	41,800	(9)	0	D

Explanation of Responses:

1. Disposed of pursuant to the Agreement and Plan of Merger and Reorganization dated as of February 3, 2015 (the Merger Agreement, and the transactions contemplated therein, the Merger), by and among the Issuer, MaxLinear, Inc. (MaxLinear), Excalibur Acquisition Corporation and Excalibur Subsidiary, LLC, whereby each share of Issuer common stock was canceled in exchange for a cash payment of $1.20 per share and .2200 of a share of MaxLinear Class A Common Stock, with fractional shares being paid in cash. The market value of MaxLinear Class A Common Stock received under the Merger Agreement was $8.53 per share on the effective date of the Merger.

2. The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 14,567 shares of MaxLinear Class A Common Stock with an exercise price of $5.56 per share.

3. The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 22,389 shares of MaxLinear Class A Common Stock with an exercise price of $6.73 per share.

4. 1/4th of the shares vested one year after the Vesting Commencement Date beginning 4/11/14. 1/48th of the shares vest monthly thereafter over the next three years. The option was assumed by MaxLinear in the Merger and replaced with an option to purchase 21,493 shares of MaxLinear Class A Common Stock with an exercise price of $10.78 per share.

5. 1/4th of the shares vested one year after the Vesting Commencement Date beginning 4/12/13. 1/48th of the shares vest monthly thereafter over the next three years. The option was assumed by MaxLinear in the Merger and replaced with an option to purchase 21,493 shares of MaxLinear Class A Common Stock with an exercise price of $11.48 per share.

6. The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 28,658 shares of MaxLinear Class A Common Stock with an exercise price of $13.57 per share.

7. 1/4th of the shares vested one year after the Vesting Commencement Date beginning 4/13/12. 1/48th of the shares vest monthly thereafter over the next three years. The option was assumed by MaxLinear in the Merger and replaced with an option to purchase 18,269 shares of MaxLinear Class A Common Stock with an exercise price of $14.24 per share.

8. The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 23,822 shares of MaxLinear Class A Common Stock with an exercise price of $20.80 per share.

9. The RSU represents a contingent right to receive Issuer common stock on a one-for-one basis. The RSU, which vests in equal annual installments, was assumed by MaxLinear in the Merger and converted into restricted stock units representing a contingent right to receive an aggregate of 14,973 shares of the Class A Common Stock of MaxLinear on the same terms and conditions (including with respect to vesting and exercisability) as were applicable to the RSU prior to the consummation of the Merger.

	Lance W. Bridges	05/04/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.